November 4, 2020
J&J to test COVID-19 vaccine in adolescents
Editor's Note
Johnson & Johnson (J&J) has announced plans to test their COVID-19 vaccine in young individuals between the ages of 12 and 18, the October 30 Reuters reports.
J&J started testing its vaccine in 60,000 volunteer adults in late September.
Depending on safety, J&J also plans to test the vaccine in younger children.
Free Daily News
- HHS report highlights cost, access, quality concerns with private equity in healthcare
- Study: Racial, gender disparities persist in bariatric surgery
- Study: Dry eye risks complicate cataract surgery recovery
- Study: Observational learning ineffective in ensuring nursing student infection control compliance
- Students innovate to reduce OR plastic waste
- OR Business Management Conference 2025 features fresh perspectives, new tracks
- Survey: Bariatric surgery’s fertility benefits not widely understood
- Study highlights nurse staffing disparity in hospitals serving black populations
- Joint Commission issues new workplace violence prevention standards
- AI outperforms experts in ovarian cancer ultrasound detection
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement